Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Perimeter Medical Imaging AI ( (TSE:PINK) ) has provided an update.
Perimeter Medical Imaging AI has entered a systemwide agreement with Intermountain Health that allows deployment of its S-Series OCT intraoperative imaging technology across the nonprofit health system’s 34 hospitals and 400 clinics in the Intermountain West, starting with operating rooms at LDS Hospital in Salt Lake City and American Fork Hospital in Utah. The collaboration expands Perimeter’s footprint into several western states where its technology has not previously been used, deepens its existing relationship with Intermountain, and positions the company to support more surgeons with advanced imaging tools that aim to improve real-time margin assessment and patient outcomes while generating additional data to advance its AI-driven imaging algorithms.
The most recent analyst rating on (TSE:PINK) stock is a Hold with a C$0.34 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.
Spark’s Take on TSE:PINK Stock
According to Spark, TipRanks’ AI Analyst, TSE:PINK is a Neutral.
The overall stock score is primarily impacted by financial performance challenges, including negative profitability and cash flow issues. While technical analysis shows bullish momentum, the valuation reflects ongoing losses, limiting the stock’s attractiveness.
To see Spark’s full report on TSE:PINK stock, click here.
More about Perimeter Medical Imaging AI
Perimeter Medical Imaging AI is a commercial-stage medical technology company based in Toronto and Dallas that develops ultra-high-resolution, real-time imaging tools to support cancer surgery. Its FDA-cleared S-Series OCT system provides cross-sectional visualization of excised tissue at the cellular level and is available across the U.S., while its next-generation B-Series OCT with ImgAssist AI, a breakthrough-designated investigational device, has been evaluated in a pivotal clinical trial to enhance surgical decision-making in areas of high unmet medical need.
Average Trading Volume: 135,208
Technical Sentiment Signal: Sell
Current Market Cap: C$36.69M
For detailed information about PINK stock, go to TipRanks’ Stock Analysis page.